These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10978398)

  • 21. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
    Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
    Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results from EuCliD (European Clinical Dialysis Database): impact of shifting treatment modality.
    Merello Godino JI; Rentero R; Orlandini G; Marcelli D; Ronco C
    Int J Artif Organs; 2002 Nov; 25(11):1049-60. PubMed ID: 12487392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
    Panichi V; Scatena A; Rosati A; Giusti R; Ferro G; Malagnino E; Capitanini A; Piluso A; Conti P; Bernabini G; Migliori M; Caiani D; Tetta C; Casani A; Betti G; Pizzarelli F
    Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 1998 Nov; 13(11):2867-72. PubMed ID: 9829492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study.
    Wizemann V; Lotz C; Techert F; Uthoff S
    Nephrol Dial Transplant; 2000; 15 Suppl 1():43-8. PubMed ID: 10737166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial correction of dialysis-associated anaemia does not reduce erythropoietin dose or the incidence of side effects.
    Mellotte GJ; Morgan SH; Smith SA; Bending MR; Eisinger AJ
    Nephron; 1993; 64(3):465-7. PubMed ID: 8341395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.
    Goicoechea M; Vazquez MI; Ruiz MA; Gomez-Campdera F; Perez-García R; Valderrábano F
    Nephron; 1998; 78(1):23-7. PubMed ID: 9453399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
    Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?
    Eschbach JW; Varma A; Stivelman JC
    Nephrol Dial Transplant; 2002; 17 Suppl 5():2-7. PubMed ID: 12091599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin and sexual dysfunction.
    Lawrence IG; Price DE; Howlett TA; Harris KP; Feehally J; Walls J
    Nephrol Dial Transplant; 1997 Apr; 12(4):741-7. PubMed ID: 9141005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial.
    Kloppenburg WD; Stegeman CA; Hovinga TK; Vastenburg G; Vos P; de Jong PE; Huisman RM
    Nephrol Dial Transplant; 2004 May; 19(5):1212-23. PubMed ID: 14993506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
    Eiselt J; Veselá E; Racek J
    Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis.
    Macdougall IC; Matcham J; Gray SJ;
    Nephrol Dial Transplant; 2003 Mar; 18(3):576-81. PubMed ID: 12584282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaemia management protocols in the care of haemodialysis patients: examining patient outcomes.
    Saunders S; MacLeod ML; Salyers V; MacMillan PD; Ogborn MR
    J Clin Nurs; 2013 Aug; 22(15-16):2206-15. PubMed ID: 23336392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.